AbbVie Inc. (ABBV) P/E Ratio History
Historical price-to-earnings valuation from 2012 to 2025
Loading P/E history...
ABBV Valuation Context
How does the current P/E compare to historical and market benchmarks?
P/E Ratio Analysis
As of May 6, 2026, AbbVie Inc. (ABBV) trades at a price-to-earnings ratio of 86.5x, with a stock price of $204.98 and trailing twelve-month earnings per share of $2.38.
The current P/E is 62% above its 5-year average of 53.3x. Over the past five years, ABBV's P/E has ranged from a low of 17.8x to a high of 173.9x, placing the current valuation at the 80th percentile of its historical range.
Compared to the Healthcare sector median P/E of 22.1x, ABBV trades at a 291% premium to its sector peers. The sector includes 242 companies with P/E ratios ranging from 0.0x to 178.0x.
Relative to the broader market, ABBV commands a significant premium over the S&P 500 median P/E of 25.2x. Investors should consider the company's growth prospects, competitive position, and earnings quality when evaluating whether the current valuation is justified.
For a comprehensive intrinsic value estimate using discounted cash flow analysis, see our ABBV DCF Valuation Calculator →
Note: P/E ratio is just one valuation metric. It does not account for balance sheet strength, cash flow quality, or growth sustainability. Always conduct comprehensive due diligence before making investment decisions.
ABBV P/E vs Peers
P/E ratio compared to closely matched public peers
| Company | Market Cap | P/E Ratio | PEG Ratio | EPS Growth (1Y) |
|---|---|---|---|---|
| $541B | 38.8 | - | -58% | |
| $280B | 15.6Lowest | 0.73Best | +8% | |
| $151B | 19.5 | - | -4% | |
| $115B | 16.4 | - | +178%Best | |
| $933B | 43.0 | 1.49 | +96% | |
| $179B | 23.3 | 7.91 | +88% | |
| $170B | 358.7 | - | -92% | |
| $28B | 21.6 | - | -21% | |
| $75B | 17.4 | 2.75 | +8% | |
| $106B | 18.4 | - | -7% |
Peers sorted by market capitalization. P/E below peers may indicate undervaluation or lower growth expectations. Consider PEG ratio for growth-adjusted comparison.
ABBV Historical P/E Data (2012–2025)
Quarterly P/E ratios calculated from closing price and TTM EPS
| Quarter | Date | Price | TTM EPS | P/E Ratio | vs Avg |
|---|---|---|---|---|---|
| FY2025 Q4 | Wed Dec 31 2025 00:00:00 GM | $228.49 | $2.37 | 96.4x | +175% |
| FY2025 Q3 | $231.54 | $1.33 | 173.9x | +396% | |
| FY2025 Q2 | Mon Jun 30 2025 00:00:00 GM | $185.62 | $2.11 | 87.9x | +150% |
| FY2025 Q1 | Mon Mar 31 2025 00:00:00 GM | $209.52 | $2.35 | 89.1x | +154% |
| FY2024 Q4 | $177.70 | $2.40 | 74.0x | +111% | |
| FY2024 Q3 | Mon Sep 30 2024 00:00:00 GM | $197.48 | $2.88 | 68.6x | +95% |
| FY2024 Q2 | Sun Jun 30 2024 00:00:00 GM | $171.52 | $3.00 | 57.2x | +63% |
| FY2024 Q1 | Sun Mar 31 2024 00:00:00 GM | $182.10 | $3.37 | 54.0x | +54% |
| FY2023 Q4 | Sun Dec 31 2023 00:00:00 GM | $154.97 | $2.73 | 56.8x | +62% |
| FY2023 Q3 | Sat Sep 30 2023 00:00:00 GM | $149.06 | $3.66 | 40.7x | +16% |
| FY2023 Q2 | Fri Jun 30 2023 00:00:00 GM | $134.73 | $4.88 | 27.6x | -21% |
| FY2023 Q1 | Fri Mar 31 2023 00:00:00 GM | $159.37 | $4.25 | 37.5x | +7% |
Average P/E for displayed period: 35.1x
Full ABBV Stock Analysis
Analyst consensus, bull case, AI-generated risk factors, and peer comparison — all in one place.
Should I Buy ABBV Right Now?
Bull case, key risks, Wall St analyst verdict, and what council investors are saying — updated daily.
See ABBV's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs ABBV Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare ABBV vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonABBV — Frequently Asked Questions
Quick answers to the most common questions about buying ABBV stock.
Is ABBV stock overvalued or undervalued?
ABBV trades at 86.5x P/E, above its 5-year average of 53.3x. The 80th percentile ranking indicates a premium to historical valuation.
How does ABBV's valuation compare to peers?
AbbVie Inc. P/E of 86.5x compares to sector median of 22.1x. The premium reflects expected growth above peers.
What is ABBV's PEG ratio?
ABBV PEG ratio is N/A. Above 2.0 indicates premium valuation relative to growth rate. Historical P/E data spans 2012-2025.